The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
journal contributionposted on 2014-01-01, 00:00 authored by C G Davey, A M Chanen, S M Cotton, S E Hetrick, M J Kerr, Michael BerkMichael Berk, Olivia DeanOlivia Dean, K Yuen, M Phelan, A Ratheesh, M R Schäfer, G P Amminger, A G Parker, D Piskulic, S Harrigan, A J Mackinnon, B J Harrison, P D McGorry
The aim of the Youth Depression Alleviation-Combined Treatment (YoDA-C) study is to determine whether antidepressant medication should be started as a first-line treatment for youth depression delivered concurrently with psychotherapy. Doubts about the use of medication have been raised by meta-analyses in which the efficacy and safety of antidepressants in young people have been questioned, and subsequent treatment guidelines for youth depression have provided only qualified support.
Pagination1 - 9
Publication classificationC Journal article; C1 Refereed article in a scholarly journal
Copyright notice2014, BioMed Central
Read the peer-reviewed publication
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalResearch & Experimental MedicineAdolescenceAntidepressantsCognitive behavioural therapyDepressionFluoxetineSelective serotonin reuptake inhibitorsYouthPLACEBO-CONTROLLED TRIALMAJOR DEPRESSIONDOUBLE-BLINDANTIDEPRESSANT TREATMENTCOMMUNITY SAMPLESELF-REPORTADOLESCENTSCHILDRENDISORDERPSYCHOTHERAPY